BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 17547116)

  • 1. [Experience of treatment of patients with gastropathy induced by non-steroid anti-inflammatory drugs].
    Vakhrushev IaM; Loshchakova OIu
    Eksp Klin Gastroenterol; 2007; (1):60-3, 71. PubMed ID: 17547116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical approach to management of patients with non-steroidal anti-inflammatory gastropathy.
    Yeomans ND
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S89-92. PubMed ID: 10379475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Omeprazole and misoprostol for NSAID-induced gastropathies: comparative efficiency of their short-term treatment].
    Karateev AE; Murav'ev IuV
    Klin Med (Mosk); 2001; 79(5):48-50. PubMed ID: 11510188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The endoscopic assessment of the effect of ranitidine and pirenzepine on the manifestations of the gastropathy induced by nonsteroidal anti-inflammatory preparations].
    Karateev AE; Murav'ev IuV; Nasonova VA
    Ter Arkh; 1997; 69(5):67-9. PubMed ID: 9235663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
    Lazzaroni M; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S73-8. PubMed ID: 10379473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of nonsteroidal anti-inflammatory drug-induced gastropathy.
    Scheiman JM
    Am J Manag Care; 2001 Feb; 7(1 Suppl):S10-4. PubMed ID: 11225347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does famotidine have similar efficacy to misoprostol in the treatment of non-steroidal anti-inflammatory drug-induced gastropathy?
    Wu CS; Wang SH; Chen PC; Wu VC
    Int J Clin Pract; 1998 Oct; 52(7):472-4. PubMed ID: 10622088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of NSAIDs-induced gastropathy.
    La Corte R; Caselli M; Ruina M; Bajocchi G; Alvisi V; Trotta F
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():37-41. PubMed ID: 9032582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications of nonsteroidal antiiflammatory drug gastropathy and use of gastric cytoprotection: experience at a tertiary care health center.
    Bakowsky VS; Hanly JG
    J Rheumatol; 1999 Jul; 26(7):1557-63. PubMed ID: 10405945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of NSAID-induced GI mucosal injury.
    Gerritz S; Newton WP
    J Fam Pract; 1997 Feb; 44(2):130-1. PubMed ID: 9040509
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of NSAID-gastropathy.
    Ardizzone S; Bianchi Porro G
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():33-6. PubMed ID: 9032581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapies for ulcers associated with nonsteroidal antiinflammatory drugs.
    Chan FK; Sung JJ
    N Engl J Med; 1998 Jul; 339(5):349-50; author reply 350-1. PubMed ID: 9696650
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-inflammatories and gastroduodenal damage: therapeutic options.
    Agrawal NM
    Eur J Rheumatol Inflamm; 1993; 13(1):17-24. PubMed ID: 7821335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of ulcer lesions under non-steroid antirheumatic agents. For each patient the appropriate stomach protection].
    MMW Fortschr Med; 2004 May; 146(22):48. PubMed ID: 15373113
    [No Abstract]   [Full Text] [Related]  

  • 16. The management of upper gastrointestinal problems in patients taking NSAIDs.
    Prichard P
    Aust Fam Physician; 1991 Dec; 20(12):1739-41. PubMed ID: 1687198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of misoprostol to ranitidine in non-responders to H2-blockers and pirenzepine.
    Walker S; Sarem-Aslani A; Treiber G; Klotz U; Bode JC
    Neth J Med; 1991 Feb; 38(1-2):18-23. PubMed ID: 1674363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.
    Miyake K; Ueki N; Suzuki K; Shinji Y; Kusunoki M; Hiratsuka T; Nishigaki H; Tatsuguchi A; Futagami S; Wada K; Tsukui T; Nakajima A; Yoshino S; Sakamoto C
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():67-72. PubMed ID: 15943850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs].
    Salentijn GJ
    Ned Tijdschr Geneeskd; 1999 Nov; 143(46):2340. PubMed ID: 10589227
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs].
    Knol A
    Ned Tijdschr Geneeskd; 1999 Nov; 143(46):2339. PubMed ID: 10589226
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.